This special supplement to The Journal of Nuclear Medicine is a detailed tabulation of
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …

A meta-analysis of the literature for the use of FDG PET in the detection of recurrent colorectal
cancer (CRC) was conducted to evaluate the quality of the reported studies. Overall …

PET/CT with 18 F-FDG is increasingly being used for staging, restaging, and treatment monitoring
for cancer patients. CT is still frequently used only for attenuation correction and lesion …

ContextDeficits in cerebral glucose utilization have been identified in patients with cognitive
dysfunction attributed to various disease processes, but their prognostic and diagnostic …

Inhibitors of the kinase mammalian target of rapamycin (mTOR) have shown sporadic activity
in cancer trials, leading to confusion about the appropriate clinical setting for their use. …

Patients with coronary artery disease (CAD) and severe left ventricular (LV) dysfunction
have a high but variable annual mortality and some may benefit from myocardial …

BACKGROUND Aging is associated with changes of the systolic blood pressure that may
increase cardiac work and myocardial blood flow at rest and reduce the myocardial flow …

… Johannes Czernin is a founder, board member, and holds equity in Sofie Biosciences and
… Johannes Czernin serves on the medical advisory board of Actinium and is a member of the …

The LKB1 (also called STK11) tumor suppressor is mutationally inactivated in ∼20% of non-small
cell lung cancers (NSCLC). LKB1 is the major upstream kinase activating the energy-…

Small-animal PET scanning with 18 F-FDG is increasingly used in murine models of human
diseases. However, the impact of dietary conditions, mode of anesthesia, and ambient …